IDO1 and depressive symptom measurement: In the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial two common SNPs in the IDO1 gene were associated with treatment outcome for either citalopram or overall antidepressant treatment (Cutler et al., 2012).